Inovio Pharmaceuticals (INO) Return on Sales [ROS] (2010 - 2025)
Inovio Pharmaceuticals (INO) reported Return on Sales [ROS] of -132871.32% for Q4 2025, down 115460.54 percentage points from -17410.77% a year earlier and down 83668.43 percentage points from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Return on Sales [ROS] (2010 - 2025) Analysis & Trends
Dating back to Q2 2010, Inovio Pharmaceuticals' Return on Sales [ROS] record includes 63 quarters.
- Return on Sales [ROS] has declined for three consecutive years, with a five-year change of -131197.07 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -51616.91% in FY2024 (-34316.64 pp), -17300.28% in FY2023 (-14692.92 pp), -2607.35% in FY2022 (+14364.98 pp) and -16972.34% in FY2021 (-15298.09 pp).
- The Q4 2025 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q2 2010.
- Year over year, Return on Sales [ROS] gained in three of the last eight quarters, with an average year-over-year change of -22813.84 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q3 2022 (a gain of 20162.55 percentage points); the low point was Q4 2025 (a drop of 115460.54 percentage points).
- Per Business Quant data, the three quarters before Q4 2025 came in at -49202.88% (Q3 2025), -52568.64% (Q2 2025) and -38336.97% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Inovio Pharmaceuticals | 94.68 Mn | 94.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -132,871.32% |
| Sep 30, 2025 | -49,202.88% |
| Jun 30, 2025 | -52,568.64% |
| Mar 31, 2025 | -38,336.97% |
| Dec 31, 2024 | -17,410.77% |
| Sep 30, 2024 | -58,709.67% |
| Jun 30, 2024 | -32,945.87% |
| Mar 31, 2024 | -18,334.78% |
| Dec 31, 2023 | -26,686.29% |
| Sep 30, 2023 | -9,152.63% |
| Jun 30, 2023 | -16,391.97% |
| Mar 31, 2023 | -38,238.24% |
| Dec 31, 2022 | -44,876.83% |
| Sep 30, 2022 | -390.61% |
| Jun 30, 2022 | -13,276.13% |
| Mar 31, 2022 | -36,033.33% |
| Dec 31, 2021 | -12,573.76% |
| Sep 30, 2021 | -20,553.16% |
| Jun 30, 2021 | -30,496.56% |
| Mar 31, 2021 | -14,161.05% |
API Access
Inovio Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();